Additional Details
-
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Cincinnati Children's Hospital Medical Center (Site #: 71017)Cincinnati OH. 45229View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
University of California, Los Angeles (Site #: 71123)Los Angeles CA. 90095View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Cleveland Clinic (Site #: 71101)Cleveland OH. 44195View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Johns Hopkins (Site #: 71119)Baltimore MD. 21287View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Duke University (Site #: 71139)Durham NC. 27710View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
MD Anderson Cancer CenterHouston TX. 77030View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteMontreal QC. H2X 0A9View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteTrois-Rivières QC. G8T 7A1View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteAjax ON. L1S 2J5View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteEdmonton AB. T6G 2C8View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteSherbrooke QC. J1H 5N4View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteVancouver BC. V6Z 2K5View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of California San FranciscoSan Francisco CA. 94143View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of MichiganAnn Arbor MI. 48109View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of KansasKansas City KS. 66103View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of Colorado DenverAurora CO. 80045View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Advocate Christ Medical CenterOak Lawn IL. 60453View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Medical College of WisconsinMilwaukee WI. 53226View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Morristown Medical CenterMorristown NJ. 07960View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
National Jewish HealthDenver CO. 80206View Details